FR2294696A1 - Nouveaux analogues de prostaglandines, leur procede de preparation et leurs applications - Google Patents

Nouveaux analogues de prostaglandines, leur procede de preparation et leurs applications

Info

Publication number
FR2294696A1
FR2294696A1 FR7539194A FR7539194A FR2294696A1 FR 2294696 A1 FR2294696 A1 FR 2294696A1 FR 7539194 A FR7539194 A FR 7539194A FR 7539194 A FR7539194 A FR 7539194A FR 2294696 A1 FR2294696 A1 FR 2294696A1
Authority
FR
France
Prior art keywords
substd
alkyl
opt
tri
mono
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7539194A
Other languages
English (en)
French (fr)
Other versions
FR2294696B1 (de
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of FR2294696A1 publication Critical patent/FR2294696A1/fr
Application granted granted Critical
Publication of FR2294696B1 publication Critical patent/FR2294696B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Furan Compounds (AREA)
FR7539194A 1974-12-21 1975-12-19 Nouveaux analogues de prostaglandines, leur procede de preparation et leurs applications Granted FR2294696A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19742460990 DE2460990A1 (de) 1974-12-21 1974-12-21 Neue prostaglandin-analoga und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
FR2294696A1 true FR2294696A1 (fr) 1976-07-16
FR2294696B1 FR2294696B1 (de) 1978-07-28

Family

ID=5934352

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7539194A Granted FR2294696A1 (fr) 1974-12-21 1975-12-19 Nouveaux analogues de prostaglandines, leur procede de preparation et leurs applications

Country Status (11)

Country Link
JP (1) JPS5186449A (de)
AU (1) AU8772775A (de)
BE (1) BE836950A (de)
DE (1) DE2460990A1 (de)
DK (1) DK581075A (de)
ES (1) ES443524A1 (de)
FR (1) FR2294696A1 (de)
LU (1) LU74076A1 (de)
NL (1) NL7514654A (de)
SE (1) SE7514447L (de)
ZA (1) ZA757872B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4212985A (en) * 1978-04-28 1980-07-15 The Upjohn Company cis-4,5-Didehydro-16-phenoxy-PGE1 compounds
SK3362000A3 (en) * 1997-09-09 2000-10-09 Procter & Gamble A compound analogous to prostaglandin f and use thereof
TR200000671T2 (tr) * 1997-09-09 2000-07-21 The Procter & Gamble Company FP agonistleri olarak yararlı aromatik C16-C20-ikameli tetrahidro prostaglandinler.
SK3382000A3 (en) * 1997-09-09 2000-10-09 Procter & Gamble A compound having structure of aromatic substituted prostaglandins and its use for the treatment of bone disorders
US6444840B1 (en) 1998-03-31 2002-09-03 The Procter & Gamble Co. C11 oxymyl and hydroxylamino prostaglandins useful as FP agonists
ID26699A (id) 1998-03-31 2001-02-01 Procter & Gamble Prostaglandin c11 oksimil dan hidroksilamino yang berguna sebagai obat
NZ513825A (en) 1999-03-05 2001-09-28 Procter & Gamble C 16 unsaturated FP-selective prostaglandins analogs
US6894175B1 (en) 1999-08-04 2005-05-17 The Procter & Gamble Company 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US20120245205A1 (en) 2009-07-29 2012-09-27 Delong Mitchell A Compositions and methods for inhibiting hair growth

Also Published As

Publication number Publication date
SE7514447L (sv) 1976-06-22
AU8772775A (en) 1977-06-23
ES443524A1 (es) 1977-05-01
DE2460990A1 (de) 1976-07-01
JPS5186449A (de) 1976-07-29
ZA757872B (en) 1976-11-24
FR2294696B1 (de) 1978-07-28
DK581075A (da) 1976-06-22
NL7514654A (nl) 1976-06-23
BE836950A (fr) 1976-06-22
LU74076A1 (de) 1976-11-11

Similar Documents

Publication Publication Date Title
FR2294696A1 (fr) Nouveaux analogues de prostaglandines, leur procede de preparation et leurs applications
Kirtland et al. Prostaglandin E1 may act as a “calcium ionophore”
IT1121462B (it) Derivati dell acido dl 9 cheto prosta trienoico particolarmente utili come medicamenti e procedimento per la loro preparazione
ES8604179A1 (es) Procedimiento para la preparacion de nuevos derivados tiazo-lidinicos
ES449162A1 (es) Un procedimiento para la preparacion de un compuesto racemi-co u 8r-antimerico.
GB1458315A (en) Prostanoic acid derivatives
US4089951A (en) Oestrus or menstrual regulation
US3829579A (en) Stable solutions of pge-type compounds
FR2399999A1 (fr) Carbamates ou esters de derives du 4-prostene-1-ol et composition pharmaceutique ou veterinaire les contenant
ES8201531A1 (es) Procedimiento de preparar alcoxi propanolaminas
IT1059533B (it) Composti mono cromonici ad attiviata farmacologica processo per la loro preparazione e composizioni contenenti detti composti monocromonici
ES531131A0 (es) Un procedimiento para preparar acido 5r,6s,8r-6-(1-hidroxietil)-2-(2-carbamoiloxietiltio)-penem-3-carboxilico
SE8104703L (sv) Hetero-prostaglandinderivat och forfaranden for framstellning derav
GB1388041A (en) Benzimidazolyl sulphides and sulphones
SE8106300L (sv) Medel i synnerhet for bladfellning pa plantor
IT1075678B (it) 15-idrossi-bicicliche prostaglandine
IT1115636B (it) 13,14-deidro-bicicliche prostaglandine
IT1079103B (it) Derivati del 9-ossido-alo-prostanoico acido
IT1072541B (it) 6(9)-ossido-prostenoici acidi
GB1464206A (de)
PT71891A (en) Process for the preparation of new 16-methoxy-16-methyl-prostaglandin e1 derivatives useful as gastroprotective agents
IT1120412B (it) Tiaprostaglandine e procedimento per la loro produzione
GB736371A (en) Improvements in or relating to methods of producing stable aqueous solutions containing vitamin b
ES8604507A1 (es) Procedimiento de preparacion de las prostaglandinas del tipo 12-epi-pgf2b
ES8406488A3 (es) Procedimiento para la preparacion de derivados de norescopolamina racemicos u opticamente activos.

Legal Events

Date Code Title Description
ST Notification of lapse